-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Downgrades Amrize to Neutral, Lowers Price Target to $52

Benzinga·09/02/2026 17:57:30
Listen to the news
JP Morgan analyst Adrian Huerta downgrades Amrize (NYSE:AMRZ) from Overweight to Neutral and lowers the price target from $57 to $52.